September is Blood Cancer Awareness Month, and advocates around the world are joining together to shine a light on…
Articles by Marisa Horak, MS
Ionis Pharmaceuticals’ experimental injection therapy sapablursen may ease symptoms of polycythemia vera (PV) and reduce the need for…
The U.S. Food and Drug Administration (FDA) has approved an oral drug for adults with pancreatic adenocarcinoma, the most common…
Safusidenib, an experimental oral treatment for people with gliomas carrying IDH1 gene mutations,…
Treating multiple myeloma with a Darzalex (daratumumab)-based combination may lead to a faster and longer-lasting response than a standard…
Adding Moleculin Biotech’s experimental chemotherapy annamycin to the approved chemotherapy cytarabine may be more effective than cytarabine alone at…
Two clinical trials evaluating cemsidomide — an oral therapy candidate from C4 Therapeutics (C4T) that aims to limit cancer…
Silexion Therapeutics has launched a Phase 2/3 clinical trial testing its experimental therapy SIL204 in combination with standard-of-care chemotherapy…
The U.S. Food and Drug Administration (FDA) has granted conditional approval to iberdomide, an oral medication to be used…
When glucose is scarce, fat cells can produce beta-OHB, a molecule that helps myeloma cells survive metabolic stress, a…